Inventor · disambiguated record
Satoshi Serada
Also filed as: SERADA SATOSHI
6 granted patents·6 pending applications·1 citations·filing 2014–2022
67Inventor score
Files withUNIV NAT CORP KOCHI UNIV7SEKISUI MEDICAL CO LTD2UNIV KEIO2NAT INST OF BIOMEDICAL INNOVATION HEALTH AND NUTRITION1
Top patents by PatentIndex Score
12 records- 0168US10077316B2Esophageal cancer marker and use thereofUNIV NAT CORP KOCHI UNIV·Filed 2014·Granted Sep 18, 2018·1 cites·18 claims
- 0267US2021340275A1Esophageal cancer marker and use thereofUNIV NAT CORP KOCHI UNIV·Filed 2021·Application pending·0 cites
- 0363US2022356265A1Anti-glypican-1-immunizing antigen receptorUNIV KEIO·Filed 2022·Application pending·0 cites
- 0454US12331092B2Leucine-rich ALPHA2 glycoprotein compositionSEKISUI MEDICAL CO LTD·Filed 2019·Granted Jun 17, 2025·0 cites·10 claims
- 0554US12222351B2Immunoassay and measurement reagent for leucine-rich alpha2 glycoproteinSEKISUI MEDICAL CO LTD·Filed 2019·Granted Feb 11, 2025·0 cites·11 claims
- 0654US11370845B2Anti-glypican-1-immunizing antigen receptorUNIV KEIO·Filed 2016·Granted Jun 28, 2022·0 cites·12 claims
- 0751US10174111B2Therapeutic drug for malignant tumorsUNIV NAT CORP KOCHI UNIV·Filed 2014·Granted Jan 8, 2019·0 cites·2 claims
- 0851US2023250188A1Humanized Anti-GPC-1 AntibodyUNIV NAT CORP KOCHI UNIV·Filed 2021·Application pending·0 cites
- 0951US2018362658A1Esophageal cancer marker and use thereofUNIV NAT CORP KOCHI UNIV·Filed 2018·Application pending·0 cites
- 1046US2019023781A1Therapeutic drug for malignant tumorsUNIV NAT CORP KOCHI UNIV·Filed 2018·Application pending·0 cites
- 1143US9611475B2Prophylactic and/or therapeutic agent for inflammatory disease, and method for screening prophylactic and/or therapeutic drug for inflammatory diseaseNAT INST OF BIOMEDICAL INNOVATION HEALTH AND NUTRITION·Filed 2014·Granted Apr 4, 2017·0 cites·5 claims
- 1240US2020308299A1Anti-gpc-1 antibodyUNIV NAT CORP KOCHI UNIV·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Satoshi Serada files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →